Suchergebnisse

"Serial no. 109-73." ; Shipping list no.: 2006-0098-P. ; Distributed to some depository libraries in microfiche. ; Includes bibliographical references. ; Mode of access: Internet.

The Medical Committee for Human Rights Is concerned with the plight of the consumer in the selection of prescription and OTC medications. The Committee charges that advertising puts undue pressure upon physicians and patients alike to use drugs beyond proper indications in the treatment and prevention of disease. Levying a host of complaints against drug advertising practices, the committee puts forth a series of recommendations, including the elimination of profits in stemming what they term Is the over-powering influence of drug advertising on prescription patterns.

Introduction:Fifty years of the War on Drugs: a moment of uncertainty /Annette Idler and Juan Carlos Garzón Vergara --Warriors, victims, and vulnerable regions: a critical perspective on the War on Drugs /Annette Idler --Part one. The changing character of the War on Drugs:Building the global drug regime: origins and impact, 1909-1990s /Paul Gootenberg --The international drug control regime: crisis and fragmentation /Christopher Hallam and David Bewley-Taylor --A forward march halted: the UNGASS process and the War on Drugs /Mónica Serrano --Part two. Between warriors and victims: the War on Drugs across vulnerable regions:South America: from acquiescence to rebellion? /Angélica Durán-Martínez --Mexico and Central America: flexibility and frameworks /Carlos A. Pérez Ricart --West Africa: securitized drugs as an existential threat? /John M. Pokoo and Kwesi Aning --The Crescent Three states: which way to go? /Philip Robins --The golden triangle: regression then reform? /Pierre-Arnaud Chouvy --Russia: beyond the global South-North framework /Ekaterina Stepanova --Part three. Between securitization and people-centered policies: a glocal perspective on the War on Drugs:Drug use and crime in the context of the War on Drugs /Nicolas Trajtenberg, Olga Sánchez de Ribera and Clara Musto --Health and human rights challenges for the international drug control regime /Damon Barrett and Kasia Malinowska-Sempruch --The 2030 sustainable development agenda and the War on Drugs /Javier Sagredo --Rethinking drug policy metrics to move beyond the War on Drugs /Robert Muggah and Katherine Aguirre --Transforming the War on Drugs: a pathway to change the current paradigm /Annette Idler and Juan Carlos Garzón Vergara.

Despite a vast number of empirical studies arguing for or against a causal relationship between illegal drug use and selling and violent behavior, the debate continues. In part this is due to methodological weaknesses of previous research. Using data from the Rochester Youth Development Study, the current study seeks to improve on prior research designs to allow for a more precise examination of the mechanisms that lead from an individual's drug use (chiefly, marijuana use in the current sample) and drug selling to violent action. Results will allow for greater confidence in making causal inference regarding a long-standing concern in the discipline.